---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-22-000106"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2022-05-27T23:59:59+00:00"
generated_at: "2026-06-25T06:15:58.162613+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tandem Diabetes shareholders elect directors, approve board declassification and say-on-pay

## Summary
- Peyton R. Howell and John F. Sheridan elected as Class III directors with ~98.6% and ~98.1% of votes cast.
- Amendment to declassify board (annual elections) approved with 99.9% of votes cast in favor.
- Non-binding advisory vote on named executive officer compensation approved with ~98.4% of votes cast.
- Ratification of Ernst & Young as independent auditor for FY2022 approved with ~97.7% of votes cast.

## SEC filing metadata
- accession: 0001438133-22-000106
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2022-05-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000106/0001438133-22-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000106/tndm-20220525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-22-000106
- JSON: https://secwatch.observer/filing/0001438133-22-000106.json
- Plain text: https://secwatch.observer/filing/0001438133-22-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.